Log inSign up
NEJM
38.2K posts
NEJM profile banner
@NEJM

NEJM

@NEJM
The New England Journal of Medicine is the world’s leading medical journal and website.
Boston, MA
NEJM.org
Joined March 2009
432
Following
1M
Followers
RepliesRepliesRepostsRepostsMediaMediaArticlesArticles

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • Pinned
    @NEJM
    NEJM
    @NEJM
    Aug 29
    Presented at #ESCCongress: In older adults without cardiovascular disease, treatment with atorvastatin led to a lower risk of major cardiovascular events than placebo at a median of 5.9 years but did not result in longer disability-free survival. Full STAREE trial results:
    Graphs from the Original Article "Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults." The trial name, STAREE, is in parentheses after the title. The graphs show the cumulative incidence of primary end-point events (death from cardiovascular causes, nonfatal myocardial infarction or stroke, or coronary revascularization, whichever occurred first). The trial results are being presented at the European Society of Cardiology Congress 2026. The logo of the New England Journal of Medicine is at the bottom.
    15
  • @NEJM
    NEJM
    @NEJM
    10h
    A 46-year-old man with cirrhosis presented with a 1-week history of left flank pain. Physical examination was notable for a large ecchymosis on the left flank that was tender to palpation. Read the full case details in the Images in Clinical Medicine article “Grey Turner’s
    Two images from the Images in Clinical Medicine article "Grey Turner’s Sign." Panel A is a photo of a large ecchymosis on the patient's left flank. Panel B is CT of the abdomen with administration of contrast material showing active extravasation of the contrast material into the left psoas muscle and retroperitoneal space. The NEJM identity sits at the bottom.
    1
  • @NEJM
    NEJM
    @NEJM
    10h
    In May 2026, two members of the U.S. Preventive Services Task Force were fired. In a new Perspective, Elizabeth Kaplan, JD, and Carmel Shachar, JD, MPH, argue that vigilance will be necessary to ensure that the panel continues to adhere to rigorous scientific methods. Read the
    A quote from Perspective published in the New England Journal of Medicine reads as follows: "In an era of increasing politicization of medical research, any moves away from evidence-based medicine … could undermine the credibility of the USPSTF’s recommendations." The Perspective is titled "The Future of the USPSTF and Evidence-Based Recommendations" and the authors are Elizabeth Kaplan, J.D., and Carmel Shachar, J.D., M.P.H. The background color is dark blue and includes the NEJM identity.
  • @NEJM
    NEJM
    @NEJM
    10h
    Drs. Tarek H. Mouhieddine and Kenneth C. Anderson summarize treatment for multiple myeloma, highlighting four-drug induction therapy, evolving transplantation strategies, tailored maintenance therapy, and in relapse, earlier use of BCMA-directed immunotherapy. Read the Review
    An image from the Review Article "Treatment Decisions in Multiple Myeloma" by Tarek H. Mouhieddine, M.D., and Kenneth C. Anderson, M.D. It shows a timeline of approved treatments for multiple myeloma.
    2
  • @NEJM
    NEJM
    @NEJM
    11h
    Severe acquired methemoglobinemia was identified in 82 migrants disembarking in Sicily, 74 of whom were treated with methylene blue. Dermal absorption of 𝘕-methylaniline was identified as the likely cause. Full results of a coordinated clinical and toxicologic investigation:
    The image is a graph showing the temporal distribution of methemoglobinemia cases according to disembarkation date between March 2024 and December 2025.
Advertisement
Advertisement